Arch Therapeutics Announces Issuance of Method-of-Use Patent Covering Self-Assembling Peptidomimetics

Patent Describes Use of Self-Assembling Peptidomimetics to Create Barriers that Prevent Movement of Bodily Fluids and Contaminants, as well as Other Applications FRAMINGHAM, MA (Marketwired Feb 2, 2017) Arch Therapeutics, Inc. (OTCQB: ARTH) ( Arch or the Company ), developer of novel liquid, gel and solid hemostatic and wound care devices, announced that the U.S. Patent and Trademark Office has issued a broad method-of-use patent for products that contain self-assembling peptidomimetics (U.S. Patent number 9,511,113). The patent is assigned to the
http://bit.ly/2jAPHVF